Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Bionano Genomics, Inc.

Bionano Genomics, Inc. (BNGO) Stock Overview

Explore Bionano Genomics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

BNGO●NASDAQ
HealthcareMedical - Instruments & Supplies
$1.49
$0.16(12.03%)
U.S. Market is Open · 14:13

Bionano Genomics, Inc. (BNGO)

Meyka AI Score

Z

Key Financials

Market Cap17.9M
P/E Ratio-0.41
EPS (TTM)$-4.37
ROE-0.79%
Fundamental Analysis

AI Price Forecasts

1 Month$-1.76
3 Months$0.00
1 Year Target$0.00

BNGO Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Bionano Genomics, Inc. (NASDAQ: BNGO) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Bionano Genomics, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of BNGO on the NASDAQ shows an RSI of 79.89, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind Bionano Genomics, Inc.'s NASDAQ-traded stock include a P/E ratio of -0.41 and a market capitalization of 17.9M. Combined with our AI analysis, these give both institutional and retail investors a clear view of BNGO on the NASDAQ.

Price Performance (NASDAQ: BNGO)

1-Day Change
17.29%
5-Day Change
32.20%
1-Month Change
32.20%
3-Month Change
34.48%
6-Month Change
40.54%
Year-to-Date (YTD) Change
1.96%
1-Year Change
-43.68%
3-Year Change
-99.20%
5-Year Change
-99.95%
All-Time (Max) Change
-99.96%

Contact Information

https://bionano.com
858 888 7600
9540 Towne Centre Drive, San Diego, CA, 92121

Company Facts

960 Employees
IPO DateAug 21, 2018
CountryUS
Actively Trading

Frequently Asked Questions